• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活的组织肾素-血管紧张素系统会加重心力衰竭的进展。

Activated tissue renin-angiotensin systems add to the progression of heart failure.

作者信息

Pinto Y M, Buikema H, van Gilst W H, Lie K I

机构信息

Dept. of Cardiology, University of Groningen, The Netherlands.

出版信息

Basic Res Cardiol. 1996;91 Suppl 2:85-90. doi: 10.1007/BF00795368.

DOI:10.1007/BF00795368
PMID:8957550
Abstract

In this paper, we review the hypothesis that activated tissue renin-angiotensin systems play a detrimental role in heart failure. The main arguments for this idea are discussed: a) tissue renin-angiotensin systems behave functionally distinct from the circulating renin-angiotensin system; b) tissue renin-angiotensin systems are activated in heart failure; c) activated tissue renin-angiotensin systems induce cardiovascular dysfunction. Finally, this hypothesis predicts that optimal treatment in heart failure requires the inhibition of tissue renin-angiotensin systems. However, studies pertaining to this prediction are still lacking, particularly in human subjects.

摘要

在本文中,我们回顾了激活的组织肾素 - 血管紧张素系统在心力衰竭中起有害作用这一假说。讨论了支持这一观点的主要论据:a)组织肾素 - 血管紧张素系统在功能上与循环肾素 - 血管紧张素系统不同;b)组织肾素 - 血管紧张素系统在心力衰竭中被激活;c)激活的组织肾素 - 血管紧张素系统会诱发心血管功能障碍。最后,这一假说预测,心力衰竭的最佳治疗需要抑制组织肾素 - 血管紧张素系统。然而,有关这一预测的研究仍然缺乏,尤其是在人类受试者中。

相似文献

1
Activated tissue renin-angiotensin systems add to the progression of heart failure.激活的组织肾素-血管紧张素系统会加重心力衰竭的进展。
Basic Res Cardiol. 1996;91 Suppl 2:85-90. doi: 10.1007/BF00795368.
2
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.心脏和血管系统中的组织肾素-血管紧张素系统:可能参与血管紧张素转换酶抑制剂的心血管作用。
Am J Cardiol. 1990 May 22;65(19):3I-10I. doi: 10.1016/0002-9149(90)90118-k.
3
[Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].[血管紧张素II对心脏的生长刺激特性:对心力衰竭治疗的影响]
Z Kardiol. 1993;82 Suppl 4:1-6.
4
Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure: implications for therapy.
Cardiology. 1993;83(1-2):38-48. doi: 10.1159/000175946.
5
The renin-angiotensin system as a target for therapeutic intervention.
J Cardiovasc Pharmacol. 1994;24 Suppl 2:S1-5.
6
The cardiac renin-angiotensin system in heart failure.心力衰竭中的心脏肾素-血管紧张素系统。
Am Heart J. 1993 Sep;126(3 Pt 2):756-60. doi: 10.1016/0002-8703(93)90925-y.
7
[Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure].血管紧张素转换酶抑制剂作为慢性充血性心力衰竭的首选药物
Pol Arch Med Wewn. 1992 Aug-Sep;88(2-3):165-70.
8
[Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].[心力衰竭中的外周和心脏适应性机制:肾素-血管紧张素系统的作用及其抑制]
Verh Dtsch Ges Inn Med. 1991;97:552-7.
9
Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.依那普利与群多普利对慢性心力衰竭患者循环及血管肾素-血管紧张素系统抑制作用的比较
Am J Cardiol. 2004 Dec 15;94(12):1501-5. doi: 10.1016/j.amjcard.2004.08.027.
10
The renin-angiotensin-aldosterone system and heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭。
Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002.

引用本文的文献

1
Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats.血管紧张素II激活的p44/42丝裂原活化蛋白激酶介导心力衰竭大鼠的交感神经兴奋。
Hypertension. 2008 Aug;52(2):342-50. doi: 10.1161/HYPERTENSIONAHA.108.110445. Epub 2008 Jun 23.
2
Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.心力衰竭中血管紧张素II与一氧化氮在交感神经传出控制中的相互作用
Heart Fail Rev. 2000 Mar;5(1):27-43. doi: 10.1023/A:1009894007055.

本文引用的文献

1
Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat.大鼠心肌梗死后心室重构中心脏血管紧张素原基因表达的选择性激活。
J Mol Cell Cardiol. 1993 Feb;25(2):133-43. doi: 10.1006/jmcc.1993.1017.
2
Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.实验性心力衰竭后心脏肾素-血管紧张素系统的选择性及时间相关性激活:与心室功能和形态的关系
Cardiovasc Res. 1993 Nov;27(11):1933-8. doi: 10.1093/cvr/27.11.1933.
3
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
雷米普利对伴有心力衰竭临床证据的急性心肌梗死幸存者死亡率和发病率的影响。急性梗死雷米普利疗效(AIRE)研究调查组。
Lancet. 1993 Oct 2;342(8875):821-8.
4
Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.衰竭的人类心脏中血管紧张素转换酶基因表达增加。通过竞争性RNA聚合酶链反应进行定量分析。
J Clin Invest. 1994 Jul;94(1):301-10. doi: 10.1172/JCI117322.
5
Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
Circulation. 1994 Nov;90(5):2457-67. doi: 10.1161/01.cir.90.5.2457.
6
Stretch-mediated activation of cardiac renin gene.伸展介导的心脏肾素基因激活。
Am J Physiol. 1994 Oct;267(4 Pt 2):H1630-6. doi: 10.1152/ajpheart.1994.267.4.H1630.
7
GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.GISSI-3研究:赖诺普利与经皮硝酸甘油单独及联合应用对急性心肌梗死后6周死亡率及心室功能的影响。意大利心肌梗死存活研究组
Lancet. 1994 May 7;343(8906):1115-22.
8
Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.TGR(mREN-2)27转基因大鼠中肾素和血管紧张素原的差异基因表达
Hypertension. 1995 Apr;25(4 Pt 1):570-80. doi: 10.1161/01.hyp.25.4.570.
9
Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats.
Eur Heart J. 1994 Dec;15 Suppl D:63-7. doi: 10.1093/eurheartj/15.suppl_d.63.
10
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.ISIS-4:一项随机析因试验,在58050例疑似急性心肌梗死患者中评估早期口服卡托普利、口服单硝酸酯和静脉注射硫酸镁。ISIS-4(第四次国际心肌梗死存活研究)协作组
Lancet. 1995 Mar 18;345(8951):669-85.